Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 6.
Figure 6.

CRISPRi repression of Fabp4 in a high-fat diet-induced mouse model. (A) Weekly body weight. (B) Fat masses for epiWAT, subWAT, and total white adipose tissue. (C) Insulin tolerance test after 6 wk of treatment. Insulin was injected intraperitoneally and blood glucose was detected at each time point, and AUC was determined. (D) Weekly food intake. Data are presented as mean ± SEM (n = 3–5). (ns) nonsignificant, (*) P < 0.05, (**) P < 0.01, (***) P < 0.001 was considered significant.

This Article

  1. Genome Res. 29: 1442-1452

Preprint Server